Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

F-18 PET/CT-Guided Lu-177 Therapy Added to Corticosteroid Injections for Chronic Plantar Fasciitis

Official title: F-18 Sodium Fluoride PET/CT-Guided Pain Palliation in Chronic Plantar Fasciitis: A Comparative Study of ¹⁷⁷Lutetium-Corticosteroid-Local Anaesthetic Injection vs Corticosteroid-Local Anaesthetic Injection

Run by Post Graduate Institute of Medical Education and Research, Chandigarh · NCT07907250 · Data updated 2026-11-12

This study tests whether adding a low-dose Lu-177 therapy guided by F-18 NaF PET/CT to standard corticosteroid injections helps relieve pain and improve function in adults with chronic plantar fasciitis who didn’t improve with conservative care.

More Plantar Fascitis trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment40 (estimated)
SponsorPost Graduate Institute of Medical Education and Research, Chandigarh
Academic / other
Drugs / interventionsradiation
Locations1 site (Chandigarh, Chandigarh)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedOctober 30, 2026
Trial IDNCT07907250 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with chronic plantar fasciitis (>6 months) who failed conservative therapy and meet PET/CT criteria for focal plantar fascia uptake.

Probably not a fit

Patients without focal uptake on F-18 NaF PET/CT or with contraindications to the study injections may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized pilot trial comparing two intralesional treatment strategies for chronic plantar fasciitis. Participants aged 18–80 with at least six months of heel pain, a baseline pain score of 4 or higher, and focal uptake on F-18 NaF PET/CT are eligible. Forty participants will be enrolled, with 20 in each arm: one group receives F-18 NaF PET/CT-guided Lutetium-177 corticosteroid and local anesthetic injections, the other receives F-18 NaF PET/CT-guided corticosteroid and local anesthetic injections alone. Primary outcomes assess changes in foot pain and function, using the designated regional measures. The study aims to determine if the Lu-177–based addition offers superior pain relief and functional gains compared with corticosteroid injections alone.

Why it matters

Potential benefit: If successful, patients could experience greater pain relief and better functional ability with a targeted, image-guided intralesional therapy.

How similar studies have gone: Prior approaches using targeted, PET/CT-guided injections have shown potential in other musculoskeletal conditions, but this specific Lu-177 plus corticosteroid strategy for plantar fasciitis is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18-80 years with chronic plantar fasciitis (\>6 months).
2. Failed to conservative therapy.
3. Baseline VAS ≥4.
4. Focal uptake at plantar fascia insertion on F-18 NaF PET/CT.

Exclusion Criteria:

1. Prior radiation therapy to the foot/heel.
2. Active infection at the injection site or systemic infection.
3. Pregnancy or lactation. (Pregnancy test for women of childbearing potential.)
4. Coagulopathy (INR \>1.5 or platelets \<100,000/µL) is not correctable.
5. Uncontrolled diabetes or severe peripheral vascular disease affecting wound healing.
6. Known allergy to agents would be used for local anaesthesia or to any component of the injection.

Where it's running

  • Postgraduate Institute of Medical Education and Research, Chandigarh
    Chandigarh, Chandigarh, India
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.